TickerFactsScreenerDevelopers

Aclaris Therapeutics, Inc. (ACRS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$20.37M2016: -$34.60M2017: -$54.66M2018: -$100.81M2019: -$96.44M2020: -$38.63M2021: -$52.13M2022: -$67.57M2023: -$78.33M2024: -$20.07M2025: -$47.11M-$47.11M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$47.11M-134.7%
2024-$20.07M+74.4%
2023-$78.33M-15.9%
2022-$67.57M-29.6%
2021-$52.13M-34.9%
2020-$38.63M+59.9%
2019-$96.44M+4.3%
2018-$100.81M-84.4%
2017-$54.66M-58.0%
2016-$34.60M-69.9%
2015-$20.37M—